Integrated Diagnostics Holdings PLC

Integrated Diagnostics Holdings PLC

IDHC · LSE · Healthcare / Diagnostics & Research

0.4795USD-0.02 (-3.33%)

Price History

Full chart

Market Stats

Previous Close0.496
Open0.497
Day Range0.4635 – 0.497
52-Week Range0.4333 – 0.8222
Volume50.50K
Market Cap318.57M
P/E (TTM)0.11
Forward P/E12.92
EPS0.05
Dividend Yield1.55%
Beta0.40
50-Day Avg0.5405
200-Day Avg0.5824

About

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOProf. Hend El Sherbini Ph.D.
  • Employees7.14K
  • Headquarters12 Castle Street, Saint Helier, Jersey, JE2 3RT, UK
  • Websitehttps://www.idhcorp.com

Leadership

  • Prof. Hend El Sherbini Ph.D.Group CEO & Executive Director · b. 1969
  • Mr. Sherif Mohamed Mohamed El ZeinyVP, Group CFO & Executive Director
  • Mr. Tarek YehiaDirector of Investor Relations

Financials

Income Statement

Currency: EGP2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue641.60M671.58M860.23M1.01B1.17B1.51B1.92B2.23B2.66B5.22B3.61B4.12B5.72B7.86B
Growth (%)-+4.67%+28.09%+17.97%+15.35%+29.36%+26.89%+15.88%+19.30%+96.69%-31.00%+14.35%+38.74%+37.34%
Cost of Revenue406.66M442.02M479.51M467.53M542.69M784.70M973.07M1.14B1.31B2.42B2.14B2.60B3.54B4.50B
Gross Profit234.93M229.57M380.72M547.32M627.93M729.56M948.38M1.08B1.34B2.80B1.46B1.52B2.18B3.35B
Gross Margin36.62%34.18%44.26%53.93%53.64%48.18%49.36%48.68%50.54%53.67%40.56%36.98%38.14%42.69%
Operating Expense169.09M96.43M135.63M279.86M161.74M189.19M263.44M292.97M357.03M542.00M629.87M786.59M967.21M1.23B
Operating Income65.84M133.13M245.09M267.46M466.19M540.37M684.94M790.84M985.55M2.26B832.19M737.76M1.21B2.12B
Operating Margin10.26%19.82%28.49%26.35%39.82%35.69%35.65%35.52%37.10%43.30%23.08%17.90%21.23%27.05%
EBITDA198.33M280.90M366.55M316.41M442.54M630.74M806.60M972.62M1.22B2.57B1.29B1.28B2.09B2.89B
EBITDA Margin30.91%41.83%42.61%31.18%37.80%41.65%41.98%43.68%46.02%49.17%35.88%31.06%36.59%36.82%
Net Income24.64M62.10M132.77M144.87M260.40M374.02M502.09M510.93M594.01M1.41B541.11M510.30M1.08B1.26B
Net Income Margin3.84%9.25%15.43%14.28%22.24%24.70%26.13%22.95%22.36%27.04%15.01%12.38%18.84%16.07%
Interest Expense-292.56K394.79K5.72M9.27M10.39M11.86M61.00M67.85M98.00M122.68M141.69M170.57M208.50M
Interest Expense % of Total Revenue-0.04%0.05%0.56%0.79%0.69%0.62%2.74%2.55%1.88%3.40%3.44%2.98%2.65%

Balance Sheet

Currency: EGP2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.44B2.28B2.24B2.48B3.05B3.11B3.43B3.76B4.18B6.24B5.30B5.77B7.13B8.60B
Total Liabilities373.76M337.90M379.58M540.83M746.22M797.72M1.03B1.40B1.75B3.44B2.85B2.67B3.63B4.46B
Total Equity2.04B1.91B1.81B1.90B2.24B2.25B2.27B2.22B2.27B2.58B2.15B2.68B2.71B3.38B
Cash333.68M264.69M252.11M387.72M683.72M685.21M412.61M408.89M600.13M891.45M648.51M674.25M1.19B1.67B
Total Debt4.46M3.70M1.48M74.57M151.80M170.72M217.44M444.80M552.08M858.74M1.18B1.18B1.47B1.61B
Net Debt-329.22M-260.99M-250.63M-313.15M-531.92M-514.50M-195.17M35.90M-48.05M-793.38M-532.09M504.95M284.01M-57.56M

Cash Flow

Currency: EGP2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow639.10M209.29M301.59M189.86M398.66M403.07M556.31M697.41M882.51M2.27B208.73M543.66M1.57B1.90B
Investing Cash Flow-22.37M-10.90M-70.29M-42.42M-137.52M-33.89M-465.61M-136.35M-124.27M-1.33B990.11M-243.94M-446.71M-552.92M
Financing Cash Flow-2.60M-276.59M-234.01M-12.77M-118.20M-370.82M-358.73M-548.74M-563.54M-647.15M-1.62B-330.46M-749.00M-851.06M
Capital Expenditure25.69M24.97M76.09M54.90M48.54M157.35M331.55M218.00M126.01M263.74M308.84M325.93M224.60M521.04M
Free Cash Flow613.41M184.32M225.50M134.97M350.12M245.73M224.76M479.42M756.50M2.01B-100.11M217.73M1.34B1.38B
Dividends Paid-267.46M229.71M6.46M88.56M376.74M434.95M450.50M450.74M478.75M1.41B-27.42M535.14M
FCF to OCF95.98%88.07%74.77%71.09%87.82%60.96%40.40%68.74%85.72%88.38%-47.96%40.05%85.68%72.64%
Dividend Paid to FCF-145.11%101.87%4.79%25.29%153.32%193.52%93.97%59.58%23.86%-1410.21%-2.04%38.68%

Earnings

Report DateMay 9, 2016Aug 23, 2016Aug 22, 2017Mar 21, 2018Aug 16, 2018Mar 21, 2019Sep 10, 2019Nov 27, 2019Mar 26, 2020Apr 28, 2020Sep 2, 2020Nov 19, 2020Jun 2, 2021Sep 2, 2021Nov 16, 2021Jun 8, 2022Sep 12, 2022Nov 17, 2022Mar 22, 2023Jun 1, 2023Aug 31, 2023Nov 16, 2023Mar 28, 2024May 30, 2024Aug 29, 2024Nov 14, 2024Apr 24, 2025Sep 2, 2025Nov 13, 2025Apr 16, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.530.760.490.21-0.740.000.290.080.300.180.17-0.000.000.000.000.00
EPS Actual0.850.820.911.460.000.000.000.000.000.000.000.000.000.530.760.490.21-0.740.000.940.080.300.010.020.000.000.930.950.670.00
Surprise-------------0.00%0.00%0.00%0.00%0.61%-224.14%0.00%0.00%-96.72%-88.47%------
Timing-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-----Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap318.57M
Enterprise Value302.71M
Trailing P/E0.11
Forward P/E12.92
PEG Ratio0.00
Price / Sales1.74
Price / Book4.05
EPS0.05
Book Value5.37
Revenue (TTM)6.76B
Gross Profit (TTM)2.75B
EBITDA2.93B
Profit Margin16.71%
Operating Margin0.00%
Return on Equity36.76%
Return on Assets18.92%
Shares Outstanding581.33M
Shares Float124.82M
Beta0.40
Dividend Yield1.55%
Dividend Rate0.01
Payout Ratio1.27%

Dividends

20261×
0.01May 28, 2026
20252×
0.02Sep 11, 20250.02Jun 12, 2025
20221×
0.12Jun 16, 2022
20211×
0.05Jul 8, 2021
20201×
0.05Sep 10, 2020
20191×
0.04May 16, 2019
20181×
0.04May 17, 2018
20171×
0.04May 11, 2017
20161×
0.01Apr 7, 2016

Stock Splits

  • Dec 24, 20204:1